BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 27428115)

  • 1. Speech therapy for children with dysarthria acquired before three years of age.
    Pennington L; Parker NK; Kelly H; Miller N
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD006937. PubMed ID: 27428115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Speech therapy for children with dysarthria acquired before three years of age.
    Pennington L; Miller N; Robson S
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006937. PubMed ID: 19821391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for dysarthria due to stroke and other adult-acquired, non-progressive brain injury.
    Mitchell C; Bowen A; Tyson S; Butterfint Z; Conroy P
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002088. PubMed ID: 28121021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-speech oral motor treatment for children with developmental speech sound disorders.
    Lee AS; Gibbon FE
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD009383. PubMed ID: 25805060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease.
    Deane KH; Whurr R; Playford ED; Ben-Shlomo Y; Clarke CE
    Cochrane Database Syst Rev; 2001; (2):CD002814. PubMed ID: 11406045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Speech and language therapy to improve the communication skills of children with cerebral palsy.
    Pennington L; Goldbart J; Marshall J
    Cochrane Database Syst Rev; 2004; 2004(2):CD003466. PubMed ID: 15106204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of speech and language therapy techniques for speech problems in Parkinson's disease.
    Herd CP; Tomlinson CL; Deane KH; Brady MC; Smith CH; Sackley CM; Clarke CE
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002814. PubMed ID: 22895931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Speech and language therapy for dysarthria due to non-progressive brain damage.
    Sellars C; Hughes T; Langhorne P
    Cochrane Database Syst Rev; 2005 Jul; (3):CD002088. PubMed ID: 16034872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interventions for childhood apraxia of speech.
    Morgan AT; Murray E; Liégeois FJ
    Cochrane Database Syst Rev; 2018 May; 5(5):CD006278. PubMed ID: 29845607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease.
    Herd CP; Tomlinson CL; Deane KH; Brady MC; Smith CH; Sackley CM; Clarke CE
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002812. PubMed ID: 22895930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Speech and language therapy interventions for children with primary speech and language delay or disorder.
    Law J; Garrett Z; Nye C
    Cochrane Database Syst Rev; 2003; 2003(3):CD004110. PubMed ID: 12918003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intervention for dysarthria associated with acquired brain injury in children and adolescents.
    Morgan AT; Vogel AP
    Cochrane Database Syst Rev; 2008 Jul; 2008(3):CD006279. PubMed ID: 18646143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Speech and language therapy for dysarthria due to non-progressive brain damage.
    Sellars C; Hughes T; Langhorne P
    Cochrane Database Syst Rev; 2002; (4):CD002088. PubMed ID: 12519567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. School-based education programmes for the prevention of unintentional injuries in children and young people.
    Orton E; Whitehead J; Mhizha-Murira J; Clarkson M; Watson MC; Mulvaney CA; Staniforth JU; Bhuchar M; Kendrick D
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010246. PubMed ID: 28026877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Speech and language therapy for dysarthria in Parkinson's disease.
    Deane KH; Whurr R; Playford ED; Ben-Shlomo Y; Clarke CE
    Cochrane Database Syst Rev; 2001; (2):CD002812. PubMed ID: 11406044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Speech and language therapy for dysarthria due to non-progressive brain damage.
    Sellars C; Hughes T; Langhorne P
    Cochrane Database Syst Rev; 2001; (2):CD002088. PubMed ID: 11406032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Speech and language therapy for dysarthria due to nonprogressive brain damage: a systematic Cochrane review.
    Sellars C; Hughes T; Langhorne P
    Clin Rehabil; 2002 Feb; 16(1):61-8. PubMed ID: 11837527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for promoting participation in shared decision-making for children with cancer.
    Coyne I; O'Mathúna DP; Gibson F; Shields L; Sheaf G
    Cochrane Database Syst Rev; 2013 Jun; (6):CD008970. PubMed ID: 23740765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Cochrane review of treatment for dysarthria following acquired brain injury in children and adolescents.
    Morgan AT; Vogel AP
    Eur J Phys Rehabil Med; 2009 Jun; 45(2):197-204. PubMed ID: 19156018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for improving communication with children and adolescents about their cancer.
    Ranmal R; Prictor M; Scott JT
    Cochrane Database Syst Rev; 2008 Oct; (4):CD002969. PubMed ID: 18843635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.